To date, the optimal dosing strategy for VTE prophylaxis in critically ill, morbidly obese patients has not been determined. [20] These patients have generally been excluded from participation in ...
Enoxaparin sodium is a subcutaneously (SC) administered low-molecular-weight heparin approved in the United States for the inpatient or outpatient treatment of deep venous thrombosis (DVT) in place of ...
Please provide your email address to receive an email when new articles are posted on . As the population ages and medical care, along with a functional life style, continues to improve the health of ...
Objectives: To compare the safety and effectiveness of two different thromboprophylactic protocols in the management of patients with spinal cord injury – one using heparin/warfarin and the other ...
Unfractionated heparin is often used as adjunctive therapy with fibrinolysis in patients with ST-elevation myocardial infarction. We compared a low-molecular-weight heparin, enoxaparin, with ...
The Department of Pharmaceuticals (DoP) has rejected a review application of Sanofi India, part of the leading multinational pharma major Sanofi, and upheld the decision of National Pharmaceutical ...
PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the ADVANCE-3 study results, published in The New England ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results